Evotec SE
Status: Publicly traded
Direct answer
Evotec SE is publicly traded on XETRA under the ticker EVT.DE.
Evotec SE functions as a global collaborator, aiding the pharmaceutical and biotechnology industries in the identification and progression of novel drug candidates. The firm is actively engaged in advancing medicinal products designed to treat a diverse array of health challenges, including diabetes and its related complications, various fibrotic conditions, infectious diseases, disorders of the central nervous...
Can you invest in Evotec SE?
Yes. Evotec SE trades publicly on XETRA as EVT.DE.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.